- Home
- IMUX vs IMPP Comparison
IMUX vs IMPP Comparison
Compare IMUX & IMPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMUX | IMPP |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | Greece |
| Employees | 66 | 49 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.2M | 228.8M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMUX | IMPP |
|---|---|---|
| Price | $14.77 | $4.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 182.6K | ★ 318.0K |
| Earning Date | 05-14-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $51.79 |
| Revenue Next Year | N/A | $6.97 |
| P/E Ratio | ★ N/A | $3.68 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $2.90 |
| 52 Week High | $15.84 | $6.57 |
Technical Indicators
Market Signals| Indicator | IMUX | IMPP |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 50.31 |
| Support Level | $0.74 | $4.94 |
| Resistance Level | $15.81 | $5.27 |
| Average True Range (ATR) | 0.90 | 0.19 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 40.69 | 71.72 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.